Cardiac arrhythmia considerations of hormone cancer therapies-Reference-Cited by-同舟云学术

Cardiac arrhythmia considerations of hormone cancer therapies

Published:2019-01-30 Issue:5 Volume:115 Page:878-894
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Barber Mary¹,Nguyen Lee S²,Wassermann Johanna³,Spano Jean-Philippe³,Funck-Brentano Christian²,Salem Joe-Elie¹²

Affiliation:

1. Department of Medicine and Clinical Pharmacology, Cardio-Oncology Program, Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, TN, USA

2. Department of Pharmacology, Sorbonne Université, INSERM CIC Paris-Est, AP-HP, ICAN, Pitié-Salpêtrière Hospital, Paris F-75013, France

3. Department of Oncology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris F-75013, France

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/115/5/878/28283344/cvz020.pdf

Reference119 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Influence of sex hormones on cancer progression;Folkerd;J Clin Oncol,2010

3. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer;Kumar;Cell,1988

4. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity;Le Goff;J Biol Chem,1994

5. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex;Rogatsky;J Biol Chem,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arritmias en personas transgénero;Archivos de Cardiología de México;2023-10-31

2. Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies;The Journal of Steroid Biochemistry and Molecular Biology;2023-10

3. Androgen Deprivation Therapy and Risk of Cardiovascular Disease in Patients With Prostate Cancer Based on Existence of Cardiovascular Risk;Journal of the National Comprehensive Cancer Network;2023-02

4. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);European Heart Journal - Cardiovascular Imaging;2022-08-26

5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);European Heart Journal;2022-08-26